We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Urinary Metabolites Are Different in Autistic Children

By LabMedica International staff writers
Posted on 15 Jun 2010
Print article
A simple urine test is under development to diagnose children with autism.

People with autism also often suffer from gastrointestinal disorders and have a different makeup of bacteria in their guts from nonautistic people.

It is possible to distinguish between autistic and nonautistic children by looking at the by-products of gut bacteria and the body's metabolic processes in the children's urine. The exact biological significance of gastrointestinal disorders in the development of autism is unknown.

In a recent study, carried out by Anglo-Australian scientists, the chemical composition of the urine of three groups of children aged between 3 and 9 was investigated. The three groups were composed of 39 children who had previously been diagnosed with autism, 28 nonautistic siblings of children with autism, and 34 children who did not have autism and did not have an autistic sibling. The urines were analyzed by nuclear magnetic resonance spectroscopy (1H-NMR), which can identify chemical molecules. Each of the three groups had a distinct chemical fingerprint, and autistic children had a different chemical fingerprint than the other two groups. Autistic children, for example, showed increased urinary excretion of nicotinic acid, high levels of urinary taurine and low levels of urinary glutamate. These biochemical changes are consistent with some of the known abnormalities of gut microbiota found in autistic individuals and the associated gastrointestinal dysfunction and may be of value in monitoring the success of therapeutic interventions.

Prof. Jeremy Nicholson, Ph.D. of Imperial College (Imperial College London, London, UK), said, "We know that giving therapy to children with autism when they are very young can make a huge difference to their progress. A urine test might enable professionals to quickly identify children with autism and help them early on." The study was published in June 2010 in the Journal of Proteome Research.

Autism affects an estimated 1 in every 100 people in the UK, and 1 in 166 children in the USA. Assessment for autism is a lengthy process involving a range of tests that explore the child's social interaction, communication, and imaginative skills. It is currently difficult to establish a firm diagnosis when children are less than 18 months of age.

Related Links:
Imperial College London


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.